Joost Boeckmans

Publikationer
Populärvetenskap och samverkan

Artiklar

Journal article: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2025;:S0953-6205(25)00055-X
Risk of hepatic decompensation or HCC is similar in patients with ALD- and MASLD-cirrhosis: A population-based cohort study.
Boeckmans J; Widman L; Shang Y; Strandberg R; Wester A; Schattenberg JM; Hagström H
Journal article: CURRENT OPINION IN TOXICOLOGY. 2024;40:100504
Adverse outcome pathway networks as the basis for the development of new approach methodologies: Liver toxicity as a case study
Vinken M
Journal article: HEPATOLOGY INTERNATIONAL. 2024;18(4):1178-1201
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease
Zhang H; Targher G; Byrne CD; Kim SU; Wong VW-S; Valenti L; Glickman M; Ponce J; Mantzoros CS; Crespo J; Gronbaek H; Yang W; Eslam M; Wong RJ; Machado MV; Yu M-L; Ghanem OM; Okanoue T; Liu J-F; Lee Y-H; Xu X-Y; Pan Q; Sui M; Lonardo A; Yilmaz Y; Zhu L-Y; Moreno C; Miele L; Lupsor-Platon M; Zhao L; LaMasters TL; Gish RG; Zhang H; Nedelcu M; Chan WK; Xia M-F; Bril F; Shi J-P; Datz C; Romeo S; Sun J; Liu D; Sookoian S; Mao Y-M; Mendez-Sanchez N; Wang X-Y; Pyrsopoulos NT; Fan J-G; Fouad Y; Sun D-Q; Giannini C; Chai J; Xia Z-F; Jun DW; Li G-J; Treeprasertsuk S; Li Y-X; Cheung TT; Zhang F; Goh GB-B; Furuhashi M; Seto W-K; Huang H; Di Sessa A; Li Q-H; Cholongitas E; Zhang L; Silveira TR; Sebastiani G; Adams LA; Chen W; Qi X; Rankovic I; De Ledinghen V; Lv W-J; Hamaguchi M; Kassir R; Mueller-Wieland D; Romero-Gomez M; Xu Y; Xu Y-C; Chen S-Y; Kermansaravi M; Kuchay MS; Lefere S; Parmar C; Lip GYH; Liu C-J; Aberg F; Lau G; George J; Sarin SK; Zhou J-Y; Zheng M-H; Ormeci N
Journal article: TOXICOLOGY. 2024;505:153814
A quantitative weight-of-evidence method for confidence assessment of adverse outcome pathway networks: A case study on chemical-induced liver steatosis
Verhoeven A; van Ertvelde J; Boeckmans J; Gatzios A; Jover R; Lindeman B; Lopez-Soop G; Rodrigues RM; Rapisarda A; Sanz-Serrano J; Stinckens M; Sepehri S; Teunis M; Vinken M; Jiang J; Vanhaecke T
Journal article: LIVER INTERNATIONAL. 2024;44(2):344-356
Liver stiffness as a cornerstone in heart disease risk assessment
Boeckmans J; Sandrin L; Knackstedt C; Schattenberg JM
Journal article: EUROPEAN JOURNAL OF PHARMACOLOGY. 2023;957:175989
Human skin stem cell-derived hepatic cells as in vitro drug discovery model for insulin-driven de novo lipogenesis
Buyl K; Vrints M; Fernando R; Desmae T; Van Eeckhoutte T; Jans M; Van Der Schueren J; Boeckmans J; Rodrigues RM; De Boe V; Rogiers V; De Kock J; Beirinckx F; Vanhaecke T
Journal article: EGASTROENTEROLOGY. 2023;1(2):e100024
Macrophages clear out necrotic liver lesions: a new magic trick revealed.
Rodrigues RM; Boeckmans J; Vanhaecke T
Journal article: ARCHIVES OF TOXICOLOGY. 2023;97(6):1825-1827
Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunities
Boeckmans J; Gatzios A; Schattenberg JM; Rodrigues RM; Rogiers V; Vanhaecke T
Journal article: LIVER INTERNATIONAL. 2023;43(6):1360-1361
Fatty liver disease at the basis of cardiac remodelling and increased heart rate: Insights from the UK Biobank
Boeckmans J; Schattenberg JM
Journal article: ARCHIVES OF TOXICOLOGY. 2023;97(5):1335-1353
Metabolic signature of HepaRG cells exposed to ethanol and tumor necrosis factor alpha to study alcoholic steatohepatitis by LC-MS-based untargeted metabolomics
Iturrospe E; Robeyns R; da Silva KM; van de Lavoir M; Boeckmans J; Vanhaecke T; van Nuijs ALN; Covaci A
Journal article: LIVER INTERNATIONAL. 2023;43(5):975-988
PNPLA3 I148M and response to treatment for hepatic steatosis: A systematic review
Boeckmans J; Gatzios A; Schattenberg JM; Koek GH; Rodrigues RM; Vanhaecke T
Journal article: PHARMACOLOGY & THERAPEUTICS. 2023;243:108353
Immune cells and their derived microRNA-enriched extracellular vesicles in nonalcoholic fatty liver diseases: Novel therapeutic targets
Yang L; Hao Y; Boeckmans J; Rodrigues RM; He Y
Journal article: VIRUSES-BASEL. 2022;14(10):2292
Healthcare-Associated COVID-19 across Five Pandemic Waves: Prediction Models and Genomic Analyses
Demuyser T; Seyler L; Buttiens R; Soetens O; Van Nedervelde E; Caljon B; Praet J; Seyler T; Boeckmans J; Meert J; Vanstokstraeten R; Martini H; Crombe F; Pierard D; Allard SD; Wybo I
Journal article: JOURNAL OF PROTEOME RESEARCH. 2022;21(4):1153-1166
Metabolic Signature of Ethanol-Induced Hepatotoxicity in HepaRG Cells by Liquid Chromatography-Mass Spectrometry-Based Untargeted Metabolomics
Iturrospe E; da Silva KM; Robeyns R; van de Lavoir M; Boeckmans J; Vanhaecke T; van Nuijs ALN; Covaci A
Journal article: CELLS. 2022;11(5):893
Transcriptomics Reveals Discordant Lipid Metabolism Effects between In Vitro Models Exposed to Elafibranor and Liver Samples of NAFLD Patients after Bariatric Surgery
Boeckmans J; Gatzios A; Heymans A; Rombaut M; Rogiers V; De Kock J; Vanhaecke T; Rodrigues RM
Journal article: BIOMEDICINES. 2022;10(1):161
From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights
Gatzios A; Rombaut M; Buyl K; De Kock J; Rodrigues RM; Rogiers V; Vanhaecke T; Boeckmans J
Journal article: JOURNAL OF HEPATOLOGY. 2021;75(3):690-705
Direct reprogramming of somatic cells into induced hepatocytes: Cracking the Enigma code
Rombaut M; Boeckmans J; Rodrigues RM; van Grunsven LA; Vanhaecke T; De Kock J
Journal article: ARCHIVES OF TOXICOLOGY. 2021;95(7):2235-2253
Infections at the nexus of metabolic-associated fatty liver disease
Boeckmans J; Rombaut M; Demuyser T; Declerck B; Pierard D; Rogiers V; De Kock J; Waumans L; Magerman K; Cartuyvels R; Rummens J-L; Rodrigues RM; Vanhaecke T
Journal article: CELL BIOLOGY AND TOXICOLOGY. 2021;37(2):293-311
Human hepatic in vitro models reveal distinct anti-NASH potencies of PPAR agonists
Boeckmans J; Natale A; Rombaut M; Buyl K; Cami B; De Boe V; Heymans A; Rogiers V; De Kock J; Vanhaecke T; Rodrigues RM
Journal article: JOURNAL OF CHROMATOGRAPHY A. 2021;1637:461807
An exploratory approach for an oriented development of an untargeted hydrophilic interaction liquid chromatography-mass spectrometry platform for polar metabolites in biological matrices
Iturrospe E; Silva KMD; Andujar BT; Cuykx M; Boeckmans J; Vanhaecke T; Covaci A; Nuijs ALNV
Journal article: TOXICOLOGY LETTERS. 2020;333:322-323
Hepatic cells derived from human skin progenitors show a typical phospholipidotic response upon exposure to amiodarone (vol 284, pg 184, 2018)
Natale A; Boeckmans J; Desmae T; De Boe V; De Kock J; Vanhaecke T; Rogiers V; Rodrigues RM
Journal article: CELLS. 2020;9(4):914
Inflammation Alters the Secretome and Immunomodulatory Properties of Human Skin-Derived Precursor Cells
De Kock J; Rodrigues RM; Branson S; Verhoye L; Colemonts-Vroninks H; Rombaut M; Boeckmans J; Neuckermans J; Lequeue S; Buyl K; Merimi M; Moussa Agha D; De Boe V; Lagneaux L; Meuleman P; Vanhaecke T; Najar M
Journal article: ARCHIVES OF TOXICOLOGY. 2020;94(4):1367-1369
COVID-19 and drug-induced liver injury: a problem of plenty or a petty point?
Boeckmans J; Rodrigues RM; Demuyser T; Pierard D; Vanhaecke T; Rogiers V
Journal article: METHODSX. 2020;7:101068
Flow cytometric quantification of neutral lipids in a human skin stem cell-derived model of NASH
Boeckmans J; Natale A; Rombaut M; Buyl K; Vanhaecke T; Rogiers V; Rodrigues RM; De Kock J
Journal article: CELLS. 2019;9(1):37
Anti-NASH Drug Development Hitches a Lift on PPAR Agonism
Boeckmans J; Natale A; Rombaut M; Buyl K; Rogiers V; De Kock J; Vanhaecke T; Rodrigues RM
Journal article: DATA IN BRIEF. 2019;25:104093
Transcriptomics data of a human in vitro model of non-alcoholic steatohepatitis exposed to elafibranor
Boeckmans J; Buyl K; Natale A; Vandenbempt V; Branson S; De Boe V; Rogiers V; De Kock J; Rodrigues RM; Vanhaecke T
Journal article: ARCHIVES OF TOXICOLOGY. 2019;93(7):1789-1805
Technological advancements for the development of stem cell-based models for hepatotoxicity testing
Natale A; Vanmol K; Arslan A; Van Vlierberghe S; Dubruel P; Van Erps J; Thienpont H; Buzgo M; Boeckmans J; De Kock J; Vanhaecke T; Rogiers V; Rodrigues RM
Journal article: PHARMACOLOGICAL RESEARCH. 2018;137:282-283
Comment to 'Letter to the editor: Human-based systems: Mechanistic NASH modelling just around the corner?'
Boeckmans J; Natale A; Buyl K; Rogiers V; De Kock J; Vanhaeckel T; Rodrigues RM
Journal article: PHARMACOLOGICAL RESEARCH. 2018;134:257-267
Human-based systems: Mechanistic NASH modelling just around the corner?
Boeckmans J; Natale A; Buyl K; Rogiers V; De Kock J; Vanhaecke T; Rodrigues RM
Journal article: TOXICOLOGY LETTERS. 2018;284:184-194
Hepatic cells derived from human skin progenitors show a typical phospholipidotic response upon exposure to amiodarone
Natale A; Boeckmans J; Desmae T; De Boe V; De Kock J; Vanhaecke T; Rogiers V; Rodrigues RM
Journal article: PLOS ONE. 2018;13(9):e0203846
Optimization of the Cohesion Index in the SeDeM Diagram Expert System and application of SeDeM Diagram: An improved methodology to determine the Cohesion Index.
Nofrerias I; Nardi A; Suñé-Pou M; Boeckmans J; Suñé-Negre JM; García-Montoya E; Pérez-Lozano P; Ticó-Grau JR; Miñarro-Carmona M
Visa fler

Artiklar

Nyheter från KI

Kalenderhändelser från KI